New Millennium Group’s Clearside Biomedical CLSD Stock Holding History

New Millennium Group’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,952	Closed	-$11.7K	–	432
2025 Q3	$11.7K	Buy	+2,952	New	+$20.1K	0.01%	209

Other funds holding CLSD

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

New Millennium Group's CLSD Position: Q4 2025 in Review

New Millennium Group sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 2,952 shares — an estimated $11.7K sold.

New Millennium Group first reported a position in CLSD in Q3 2025 and held it in 1 quarter. The position peaked at $11.7K in Q3 2025. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.

New Millennium Group reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
New Millennium Group sold 2,952 Clearside Biomedical shares in Q4 2025, an estimated $11.7K.
New Millennium Group first reported a position in Clearside Biomedical in Q3 2025 and held it in 1 quarter.
New Millennium Group's Clearside Biomedical position peaked at $11.7K in Q3 2025.
1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.